Saraban, Alma I.

HRN: 21-89-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
CEFUROXIME 750MG (VIAL)
11/17/2022
11/22/2022
IVTT
750mg
Q8hrs
Parasitic Infection, UTI
11/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/17/2022
11/22/2022
IVTT
500mg
Q8hrs
Parasitic Infection
Waiting Final Action 
11/19/2022
MEBENDAZOLE 500MG (TAB)
11/19/2022
11/19/2022
PO
500mg
Single Dose
Parasitic Infection
Waiting Final Action 
11/21/2022
MEBENDAZOLE 500MG (TAB)
11/21/2022
11/21/2022
ORAL
500mg
1
Parasitic Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: